Research has shown that migraines are linked to inflammation.
A clinical trial examined Coenzyme Q10βs (CoQ10βs) effects on episodic migraines in women, finding significant reductions in migraine frequency, duration, severity. CoQ10 also reduced the levels of TNF-Ι and CGRP, a peptide linked to migraines that promotes inflammation and pain signaling.
AΒ meta-analysis of five studies concluded that CoQ10 supplementation is more effective than a placebo in reducing migraine occurrence and duration in both children and adults.
βThe results support the use of CoQ10 as a potent therapeutic agent with respect to migraine duration and migraine days/month.β (Zeng et al., 2018)
These findings were corroborated in a subsequent meta-analysis of six clinical trials that showed CoQ supplemented as a preventative measure was effective for reducing the duration and frequency of migraines.
Leading the companyβs engagement in transformative research. She is committed to scientific integrity in the health and wellness space and data transparency with consumers.
She holds a Ph.D. in Biochemical and Molecular Nutrition from Tufts University and has over ten years of nutrition science research experience, exploring various dimensions of human well-being in academic and government laboratories.
Key Points Creatine + HMB improved multiple strength and endurance measures Strength gains occurred mostly without increases in muscle mass Fat mass decreased slightly Placebo produced minimal or no improvements...
Key Points Liposomal CoQ10 had 31% higher peak blood concentration Total CoQ10 levels in the blood were higher and stayed elevated longer Absorption improved even in a fasted state Both...
Skip to content
